There is a lack of published literature on systemic therapeutic options in cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma (LAHNSCC) undergoing chemoradiation ...
LONDON & NEW YORK & TOKYO--(BUSINESS WIRE)--Today KORTUC Inc., a Japanese clinical-stage biopharmaceutical company focusing on the clinical and product development of a novel radiosensitizer improving ...
ROCKVILLE, Md., July 30, 2012 /PRNewswire/ -- Radiation Control Technologies, Inc. (RCTI), a private development stage biopharmaceutical company developing RCT1938, a novel radiosensitizer that ...
If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more. To test the hypothesis that radiotherapy (RT) of head and ...
The anti-cancer drug 5-fluorouracil (5FU) acts as a radiosensitizer: it is rapidly taken up into the DNA of cancer cells, making the cells more sensitive to radiotherapy. A new study using mass ...
The high and specific expression of Kita-Kyushu lung cancer antigen 1 (KK-LC-1) in multiple types of tumors makes it an ideal target for drug delivery. In a publication, researchers from Nanjing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results